Jean-Marc Bellemin
Förmögenhet: 494 522 $ per 2026-08-31
Förmögenhet: 494 522 $ per 2026-08-31
Jean-Marc Bellemin is currently the Group Chief Executive Officer at CHIESI Farmaceutici SpA since 2026.
Formerly, Mr. Bellemin was CFO, Treasurer & Chief Accounting Officer at Iovance Biotherapeutics, Inc. from 2021 to 2025.
Prior to that, served as Chief Financial Officer & Executive Vice President at Gritstone bio, Inc. from 2018 to 2020.
Also worked as Senior Vice President-Business Solutions at Actelion Pharmaceuticals US, Inc. from 2008 to 2017.
Education includes an MBA from ESSEC Business School and graduate studies at Université Paris II Panthéon Assas.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-06-02 | 60 529 ( 0,01 % ) | 494 522 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Verkställande Direktör | 2026-05-15 |
| Företag | Position | Slut |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Finansdirektör/CFO | 2025-06-30 |
| GRITSTONE BIO, INC. | Finansdirektör/CFO | 2020-12-11 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Företagsledare/Principal | 2017-12-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Health Technology |
Université Paris Dauphine-PSL
Université Paris Dauphine-PSL Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESSEC Business School
ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Paris II Panthéon Assas
Université Paris II Panthéon Assas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Health Technology |
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Gritstone bio, Inc.
Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån